Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.780
+0.200 (7.75%)
At close: Apr 25, 2025, 4:00 PM
2.780
0.00 (0.00%)
After-hours: Apr 25, 2025, 4:43 PM EDT
Orchestra BioMed Holdings Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Orchestra BioMed Holdings stock have an average target of 15, with a low estimate of 12 and a high estimate of 20. The average target predicts an increase of 439.57% from the current stock price of 2.78.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Orchestra BioMed Holdings stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +619.42% | Apr 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +331.65% | Apr 4, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 | Strong Buy | Maintains | $20 | +619.42% | Apr 1, 2025 |
| BTIG | BTIG | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +331.65% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +403.60% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
3.36M
from 2.64M
Increased by 27.37%
Revenue Next Year
4.79M
from 3.36M
Increased by 42.68%
EPS This Year
-2.03
from -1.66
EPS Next Year
-1.85
from -2.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.4M | 4.9M | 4.9M | ||
| Avg | 3.4M | 4.8M | 4.8M | ||
| Low | 2.5M | 4.6M | 4.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 67.2% | 46.9% | 2.9% | ||
| Avg | 27.4% | 42.7% | - | ||
| Low | -3.4% | 37.1% | -3.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.97 | -1.85 | -1.89 | ||
| Avg | -2.03 | -1.85 | -1.84 | ||
| Low | -2.04 | -1.83 | -1.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.